PASG
PASG
NASDAQ · Biotechnology

Passage Bio Inc

$6.38
-0.51 (-7.40%)
Financial Highlights (FY 2025)
Revenue
4.14M
Net Income
-270,468
Gross Margin
37.5%
Profit Margin
-6.5%
Rev Growth
-4.9%
D/E Ratio
0.13
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 37.5% 37.5% 37.5%
Operating Margin -7.3% -7.5% -8.4%
Profit Margin -6.5% -5.9% -6.4%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 4.14M 4.29M 4.24M
Gross Profit 1.55M 1.61M 1.59M
Operating Income -304,151 -320,801 -354,845
Net Income -270,468 -254,054 -270,426
Gross Margin 37.5% 37.5% 37.5%
Operating Margin -7.3% -7.5% -8.4%
Profit Margin -6.5% -5.9% -6.4%
Rev Growth -4.9% +3.8% -2.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.81M 1.85M 2.19M
Total Equity 14.22M 12.92M 13.95M
D/E Ratio 0.13 0.14 0.16
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -483,031 -431,767 -494,923
Free Cash Flow -204,723 -222,413 -294,472